home / stock / okyo / okyo news


OKYO News and Press, OKYO Pharma Limited From 03/14/23

Stock Information

Company Name: OKYO Pharma Limited
Stock Symbol: OKYO
Market: NASDAQ
Website: okyopharma.com

Menu

OKYO OKYO Quote OKYO Short OKYO News OKYO Articles OKYO Message Board
Get OKYO Alerts

News, Short Squeeze, Breakout and More Instantly...

OKYO - UBER, LYFT Stocks Rise as California Court Rules Drivers Are Contractors

2023-03-14 09:54:11 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Uber (NYSE: UBER ) stock and Lyft (NASDAQ: LYFT ) stock are on the rise Tuesday after a court ruled that the companies’ drivers are contractors . ...

OKYO - Why Is OKYO Pharma (OKYO) Stock Down 10% Today?

2023-03-14 09:24:15 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips OKYO Pharma (NASDAQ: OKYO ) stock headed lower on Tuesday after the company revealed details of a stock offering for its American Depositary Shares (ADSs). OKYO Pharma has r...

OKYO - OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR IN OR INTO ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUN...

OKYO - OKYO Pharma to raise ~$5.3M in ADS offering, stock falls 5%

2023-03-13 17:06:25 ET OKYO Pharma ( NASDAQ: OKYO ) on Monday priced the public offering of 3.5 million American Depositary Shares at $1.50 per ADS. The gross proceeds from the offering is expected to be about $5.3 million. The offering is expected to close on March 15, 20...

OKYO - OKYO Pharma Limited Prices $5.3 Million Offering of ADSs

LONDON, March 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases (“DED”) a...

OKYO - Why Is Helbiz (HLBZ) Stock Up 37% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: MarbellaStudio / Shutterstock.com Helbiz (NASDAQ: HLBZ ) stock is on the move Wednesday despite a lack of hard news concerning the electric bike and scooter company. Instead, heavy trading volume is the ma...

OKYO - XPEV Stock Alert: What to Know as Xpeng Reports February Vehicle Deliveries

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Koshiro K / Shutterstock Xpeng (NYSE: XPEV ) stock is worth checking on Wednesday after the EV company released delivery data for February. During February 2023, Xpeng delivered a total of 6,010 Smart EVs...

OKYO - Why Is Novavax (NVAX) Stock Down 26% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: benjamin poturak / Shutterstock.com Novavax (NASDAQ: NVAX ) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business. In its latest earnings report, Novavax...

OKYO - Why Is OKYO Pharma (OKYO) Stock Down 31% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock OKYO Pharma (NASDAQ: OKYO ) stock is taking a beating on Wednesday despite recent progress toward a clinical trial . The latest news from OKYO Pharma is that its GMP-packaged OK-101 drug for ...

OKYO - Okyo stock pops as eye drug package gets customs clearance to enter US

London-based Okyo Pharma ( NASDAQ: OKYO ) it received customs clearance in the U.S. for its GMP packaged OK-101 drug, shipped from Europe, to be used in an upcoming phase 2 trial in patients with dry eye disease (DED). Okyo expects the first-patient-first visit in Q1 2023 an...

Previous 10 Next 10